chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient seemed to be fine right after I administered the vaccine.  She sat in our room for 15 minutes then left.  She came back shortly saying she was feeling a little funny so she wanted to sit in our room.  She left again after several minutes then came back around 5:20 saying she felt like she was going to pass out.  I told her to sit in our waiting room.  She said she felt faint and had tightness in her chest. I called the paramedics who arrived shortly after.  They said she had anxiety.  She was anxious before and after receiving the vaccine.  She left on her own.
SEVERE REACTION TO VACCINE; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced severe reaction to vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe reaction to vaccine was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case is assessed as non-serious.
First pregnancy, 9 weeks along at time of vaccine. Due date is approaching. For two days after the injection site was sore but was fine after. Exactly seven days after the vaccine the injection site was swollen and more painful than the original soreness. I?m reporting this the same day symptoms came back. Feel free to follow up as needed.
Slowly, I started getting achiness in my arm and then it went to the other arm. Then, it got to be tightness in both arm and shoulders. It got so bad that I could not move my arms. After a month or so, it starting going to my knees, ankles, and hands. I went to the doctor about this. He referred me to an Ortho doctor. They did x-rays, normal results. Then, I could not walk. He prescribed me steroids. It seem to help and then after I stopped it came back. Then, I was referred to physical therapy. Then, I was referred to rheumatologist. They did blood work, shows that I have polymyalgia rheumatic and satiation rates were high. I am still on steroids now.
Temporary paralysis of legs (about 15 min) following  small uncontrollable spasms in arms and legs  (about 20 min). Eventually, I could move my legs slowly again but they were very delayed. Needed help to walk for the next 12 hrs and my legs were very delayed and my feet dragged on the floor. Legs and arms feel delayed for weeks afterward and ongoing. I also had shortness of breath, extreme weakness, brainfog, anxiety, nausea and migraine during this period. (Day 6 - 8 were these most severe symptoms).  On days 1-3,  I had a sore arm, muscle pain in legs, chills, nightsweats and pain and pressure in my head.  On day 25 I had a few minutes of the same small spasms in my arms and legs and also the top of my spine. Legs were weak but I could move them. I?m currently  still having some shortness of breath  and legs and arms feel slightly delayed.
Day 2 after vaccination- nausea, fatigue, soreness at injection site, warmth to injection site Day 5 itchiness, redness, swelling, firm, warmth at injection site measuring 45mm diameter, intermittent nausea  Fatigue lasts for 2 days
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patient's medical histories, concurrent conditions and concomitant therapies were not reported. On an unspecified dates, the patients received an improperly stored doses of VAQTA (dose and route of administration were not provided) (lot numbers: J005081, expiration date: 22-OCT-2015; K009506, expiration date: 22-SEP-2016; K007791, expiration date: 22-AUG-2016; K024697, expiration date: 28-APR-2017; J005713 expiration date: 25-OCT-2015; reported as "K010535" expiration date: unknown; K015827, expiration date: unknown; L004743, expiration date: unknown). No adverse effect were reported. No product quality complaint (PQC) was involved. Lot # K010535 is an invalid lot # for hepatitis A vaccine, inactivated. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a physician via a company representative refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with an unspecified dose of GARDASIL (INJ) (dose, route, lot number and expiration date not reported). There was no concomitant medication reported. The reporting physician stated that the patient received GARDASIL at an unspecified time in the past that was "off schedule". No adverse effects reported. Additional information has been requested.
pt recv vax & became pregnant (LMP 26DEC98);pt had a spontaneous abortion which required a D&C the eleventh week mark;
1 of 5 pts who were vaxed from the same lot# & exp an adverse event;pt recvd vax 8JUN95 9PM;the following morning pt was very anxious & disoriented;pt reported to nurse that had terrible dreams that noc;pt has COPD & more diff breathing
Bell's Palsy, herpes zoster, mouth sore and left facial numbness; Bell's Palsy, herpes zoster, mouth sore and left facial numbness; Bell's Palsy, herpes zoster, mouth sore and left facial numbness; Bell's Palsy, herpes zoster, mouth sore and left facial numbness; This initial spontaneous report was received from a lawyer on 27-MAR-2020, regarding a case in litigation and refers to a male patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medication were not reported. On or around 15-SEP-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (the dosage regimen information was not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving the vaccine, the patient suffered severe acute left sided numbness as well as his mouth developing pus pockets and his left eyelid drooping. The patient was diagnosed with Bell's palsy, herpes zoster, mouth sore and left facial numbness. As a direct and proximate result of vaccination, the patient's symptoms had resulted in physical limitations not present prior to vaccination. He suffered mental and emotional distress due to resulting physical limitations and seriousness of his condition. He sustained severe, serious, progressive, permanent and incurable personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. He suffered and incurred damages, including medical expenses, the loss of accumulations and other economic and non-economic damages.  The reporter considered the adverse events as disabling.
Small knot with redness at injection sire, arm swollen down to elbow, warm to touch. Patient complains of pain to touch or movement. Given cold compress instructions along with benadryl. Prescribed prednisone 50mg.
Two days after getting his first Moderna Covid vaccine shot my father suddenly lost his ability to hear from his left ear.
Paresthesia. Intense pins and needles originating in thighs. Sensation spread to arms and cheeks. Lasted less then one hour after initial injection but has returned within the past 72 hours sporadically. Also experiencing muscle pain in legs, which is a known side effect. Left leg and calf more effected.
cannot walk; left leg from hip to knee, severe ache; This is a spontaneous report from a contactable other-HCP (patient himself). A 65-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6198) via an unspecified route of administration in left arm on 25Feb2021 16:30 as single dose for covid-19 immunization. Patient was 65-years-old at the time of vaccination. Patients medical history and  concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced left leg from hip to knee, severe ache, cannot walk, very painful on 26Feb2021 05:00. No treatment received for reported adverse event. The outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Itching, redness and swelling around injection site, beginning approx one week after first dose
The night of my booster shot I was feeling very fatigued. I was not able to stand long at all. I was having hot and cold flashes. Mostly hot flashes. I was also lightheaded, had diarrhea, feeling disoriented and my body ached. I was also running a temperature. I'm not sure of the temp, but it was higher than normal. I had a virtual visit with my doctor on 01/10/2022. She said the vaccination was foreign to my body and I needed to just go through it. She advised I take Metamucil D as well as Motrin rotated with Tylenol. These symptoms lasted about a week then I started to feel normal again.
Patient has a feeling of 'squishiness' in arm where injected, with slight soreness. It's as if there is a build-up of fluid from the vaccine itself.
Extreme redness and swelling starting in a small area on front of upper left arm (not where shot was given) and then spreading during second day to half of upper left arm, armpit to elbow - hot to the touch. Prescribed Prednisone 20 mg - 2 tabs for 5 days, 1 tab for 5 days.
I could not catch my breathe.  I stumbled into the hospital.  I was disoriented from not being able to get enough oxygen.  They gave me a breathing treatment with Albuterol and Ipratropium.  Methylprednisolone Sodium Succinate Injectable 125mg.  Prescription Prednisone 20mg. This is highly usual to go this long with not going back to normal.
My left arm is still hurting very badly since my vaccination. It has been a year and I have to keep my arm propped up or if I try to move my arm around to my back or lift it to my shoulder or head it hurts. I have lost strength in my arm and hand.
Site: Pain at Injection Site-Mild. Additional details: Patient reported after about a week pain in shoulder increased to a 7 on as scale from 1-10. Her provider prescribed a steroid. Now the pain is less than a 1 with a twinge here and there. Provider wanted to do MRI, but she wants to wait because her pain subsided considerably since finishing the steroid.
Patient reported feeling lightheaded, with odd/funny taste in mouth, and had elevated blood pressure (191/130, and 184/121). O2 sat was 98%
Observation volunteer alerted rapid repsonse team.  Upon assessment client states she is having trouble breathing.  VSS, no other symptoms.  Clients states she has anxiety and had a similar reactoin to the first dose.  States concened that she will miss work tomorrow due to immune response.  Feels very anxious.  Emotional support given and to be observed for 30 minutes. Symptoms resolved by the end of the observaiton period.  No futher issues. MSN, RN
patient swelled up really large. had to remove rings and clothing. also felt very badly with headache for the next few days.
Vaccines inadvertently administered second set of catch up vaccines early. First set administered 7-28-2016. Telephone call to child's father - through interpreter - revealed no adverse effects - denied fever. Some mild arm discomfort.
Around 4-5 hours after the vaccine I developed hives on my neck, chest, face, and legs.  I continued to get new hives for about 72 hours, although I developed fewer over time.  My right eye also swelled up within 4-5 hours of receiving the vaccine.  It went back to normal after about 10-12 hours.
This case was reported by a physician via a sales representative and described the occurrence of injection site redness in a subject of unspecified age and gender who was vaccinated with KINRIX. On an unspecified date the subject received unspecified dose of KINRIX (unknown). At an unspecified time after vaccination with KINRIX, the subject experienced injection site redness and swelling The events resolved after two to three days. In the reporter's opinion, the injection site redness was probably related to treatment with KINRIX. The causality of injection site swelling was unknown. It was reported that KINRIX was administered to about 10 subjects and that 7 or 8 of them experienced swelling or redness at the injection site. All have resolved after two to three days. Follow-up received as quality statement prepared on 27 May 2009: The batch of KINRIX meth the requirements of the specifications and a confirmed as suitable for vaccination purpose.
woke up in the middle of the night (3AM) with a fever; This is a spontaneous report received from a non-contactable consumer (Patient herself). A 66-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) vis an unspecified route of administration on 04Feb2021 10:00 at single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient previously took BNT162B2 in Jan2021. It was reported as patient was fine and engaged in physical activity during the day of second dose but woke up in the middle of the night (3AM) with a fever on 05Feb2021 03:00 and is currently recovering at home in bed. Patient did not receive any treatment for event. Outcome of event was recovering.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
4 year old female kid received Boostrix as a 5th dose of the Dtap series instead of a Dtap vaccine; 4 year old female kid received Boostrix as a 5th dose of the Dtap series instead of a Dtap vaccine; 4 year old female kid received Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 4-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number DD7F7, expiry date 06-DEC-2025) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: 4 year old female kid received Boostrix as a 5th dose of the Dtap series instead of a Dtap vaccine), adult product administered to child (Verbatim: 4 year old female kid received Boostrix as a 5th dose of the Dtap series instead of a Dtap vaccine) and underdose (Verbatim: 4 year old female kid received Boostrix).  The outcome of the wrong vaccine administered, adult product administered to child and underdose were unknown.   Additional Information: GSK Receipt date: 10-OCT-2023 Office Manager reported that a 4 year old female kid received Boostrix as a 5th dose of the Dtap series instead of a Dtap vaccine which led to Wrong vaccine administered, adult product administered to child and underdose. The reporter consented to follow up.
Pain/swelling/heat at injection site, chills, nausea (no vomiting), joint ache (knees and hips).  All symptoms (except soreness at injection site) resolved within 24 hours.  Soreness resolved after ~ 96 hours.
I had pain in my arm for several days after injection.  Pain went away.  8 days after injection the pain returned. Same place in my arm as before. There is pain when I move my arm. Some movements hurt more than others. Over my head and reaching backward. Such as reaching to put on my seatbelt in the car or tying an apron string  at my back.
p/vax pt devel generalized rash (hives) beginning 8/14 PM;parents noted swelling of hands AM of 8/15 accompanied by recurrence of hives;seen @ ER & DPH prescribed q 4-6hr;rash reoccurs/subsides p/DPH;
At about 2am, the patient reported feeling itchy all over and had face swelling. At this point, her tongue started to swell. She was brought to the ER where she received steroids and recovered.
Acute cellulitis of left deltoid.  She had pain with swelling and tenderness and spiked temp to 38.6.
It was reported that a pt (8 of 10) received a Fluzone SV '00-'01 on 9 Oct 2000. Reportedly within 48 - 72 hours post vaccination the pt complained of pain, redness, swelling and induration at the injection site. No specific provided, further information requested.
Administered to unauthorized age group; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered to unauthorized age group) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered to unauthorized age group). On 10-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered to unauthorized age group) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.  This report refers to a case of Product administered to patient of inappropriate age for mRNA-1273, lot # 044A21A,  with no associated AEs.; Sender's Comments: This report refers to a case of Product administered to patient of inappropriate age for mRNA-1273, lot # 044A21A,  with no associated AEs.
Had debilitating uterine/ menstrual cramps and on / off period from June 28 to July 28; disrupted sleep and physical activity, took tramadol and additional celebrex/ tylenol to manage pain
Given flublok instead of fluzone for a patient who is 13 years old. Pt has had no adverse reactions.
This spontaneous report was received from a medical assistant regarding an unknown number of patients of unknown age and gender. On unspecified dates the patients were vaccinated with LIQUID PEDVAXHIB (lot number and expiration date not reported) (dose and route not specified). Other suspect therapies included GARDASIL (lot number and expiration date not reported) (dose and route not specified), and tetanus and diphtheria toxoids, adsorbed (manufacturer unknown) (lot number and expiration date not reported) (dose and route not specified). The reporter stated that doses of LIQUID PEDVAXHIB, GARDASIL and tetanus and diphtheria toxoids, adsorbed (manufacturer unknown) were administered to an unspecified number of patients on unspecified date after being exposed to 30F for 1 hour. No adverse effects reported. Additional information has been requested.
2.5 cm induration in Left upper arm(deltoid) region 2 days after adminstration. Pt also reports redness, swelling, warmth.
I was considered fully vaccinated by June 4th (two weeks after the 2nd dose of the vaccine). In August 2021, I began to notice I was having shortness of breath, and throughout the month it got worse. I was getting winded while walking briskly down the street, or talking while walking slower. I began to also start suffering what felt like asthma attacks similar to when I was a child - but those were always excerciseinduced. By early Sept, it was constant and pretty bad, to the point I asked my doctor for a rescue inhaler and was also put on Singular (asthma medicine). I also noticed throughout August that I was having huge dark spots float through or completely block out my vision. (continued)
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 26-FEB-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml, (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 48 hours with the lowest recorded temperature of 32 Fahrenheit degree.The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this type of vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Erythema multiforme on palms of hands, feet, ankles, knees, elbows and face 10 days post vaccine.
Symptoms started to appear six days after my first shot. On the morning of 4/19, I woke up with sharp and stabbing chest pain which radiated to my back. I was unable to take full breaths. This chest pain continued for two weeks. In addition to the chest pain and inability to take a full breath, I also felt chest discomfort, like my chest was full of something. Wooziness (feeling like I?m going to faint), weakness, and heart palpitations also accompanied my symptoms. Sometimes, my heart palpitations s are so bad that it shocks my body. These symptoms are still here, 2 months after getting my first shot.
Approximately 3 minutes after injection, I became flushed, light headed, and nauseated. I did not contact anyone at the time, as I was waiting for the effects to pass. I stayed at the facility for 20 minutes before leaving, as the effects finally passed. However, the injection site is still sore and warm to the touch, 3 days after the initial injection.
First dose 50 days ago, second dose has not been given yet; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First dose 50 days ago, second dose has not been given yet) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose 50 days ago, second dose has not been given yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First dose 50 days ago, second dose has not been given yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported.   No treatment medication was reported.
patient reports muscle aches, chills, nausea, fatigue headache that started last night. states recieved COVID vaccine yesterday.
11/11/2021  2:30pm:  Body Aches and Chills 11/12/2021 7:00am:   It felt my heart was hurting but went away at 8am.
Urticarial rash on chin, face, trunk in patches; Benadryl 50mg dose every 6 hours as needed for rash recommended.
Extreme fever chills bodyaches and fatigue Unable to perform daily duties for 3 days.  Also shingles out break 1 week +1 day post shot
Information has been received from a registered nurse concerning a 19 year old female who on 14-AUG-2008 was vaccinated with the third dose of GARDASIL. On approximately 15-AUG-2008 the patient developed a "strep infection" and was placed on steroids. The patient recovered without incidence. The patient sought medical attention at the office. Additional information has been requested.
Patient experienced some numbness locally at injection site and surround areas. Patient was put under observation. for 25 minutes. Patient then felt better and left the site. Patient was instructed to contact physician or seek medical care if symptoms get worse or unable to move arm due to the numbness.
No adverse event. Pt was given BEXSERO instead of TRUMENBA as a second dose.